Sponsored symposium by Guerbet
Tuesday, July 5, 2022 10:35 AM to 11:05 AM · 30 min. (Europe/London)
Industry
Information
Use of real-life safety data from international pharmacovigilance databases to assess the importance of symptoms associated with gadolinium exposure (SAGE) in patients exposed to gadolinium-based contrast agents (GBCAs)
Dr Imran Shahid, Global Head of Medical Information, Guerbet
Viewing options
In-person
Location
Exhibition theatre 2